{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~5 mi. (Holmdel, New Jersey, +825 more cities)
facility
Bayshore Community Hospital
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~5 mi. (Holmdel, New Jersey, +954 more cities)
facility
Bayshore Community Hospital
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
city
~9 mi. (Red Bank, New Jersey, +388 more cities)
facility
Riverview Medical Center/Booker Cancer Center
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +2 more types
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~10 mi. (Hamilton, New Jersey, +469 more cities)
facility
The Cancer Institute of New Jersey Hamilton
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types